ZARZA We are Zarza, the prestigious firm behind major projects in information technology.

CME

Por: ReachMD

407 episodios disponibles

Latest episodes of the podcast CME

Mostrando página 11 de 21

Moving Forward–What Is on the Horizon? Personalized Therapies for Patients 30/04/2025

Enhancing Diagnosis, Treatment, and Outcomes in Paroxysmal Nocturnal Hemoglobinuria with Novel Oral Therapeutics 25/04/2025

Chairperson Perspective: Improving HR+/HER2- Breast Cancer Outcomes with TROP2 Antibody-Drug Conjugates 18/04/2025

HER2 Testing: The Evolving Role of Immunohistochemistry (IHC) 15/04/2025

Chairperson Perspective: Core Concepts for Community-Based Practice: The Evolving Role of Bispecific Antibody Therapy in Relapsed or Refractory Follicular Lymphoma 15/04/2025

Revolutionizing Diagnostic Precision: AI-Driven Approaches in Digital Pathology and HER2 Expression 04/04/2025

Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers 03/04/2025

Treatment Advances in Generalized Myasthenia Gravis: Clinical and Laboratory Criteria for Diagnosis and Optimal Treatment Selection 02/04/2025

Living with gMG: Navigating Personal, Professional, and Mental Health Challenges 02/04/2025

Diagnostic Advances in gMG: Effective Tools and Techniques 02/04/2025

Autoantibodies Explained: Anti-AChR, Anti-MuSK, and Their Diagnostic Role 02/04/2025

Traditional MG Treatments: Balancing Benefits, Risks, and Side Effect Management 02/04/2025

A Scientific Look at FcRn Antagonists: Mechanisms of Action Explained 02/04/2025

New Frontiers in MG: How FcRn Antagonists Are Changing MG Therapy 02/04/2025

Managing Side Effects in FcRn Therapy: Best Practices for gMG 02/04/2025

Ocular to Generalized MG: How and Why the Disease Evolves 02/04/2025

Preventing Myasthenic Crisis: Early Signs and Critical Interventions 02/04/2025

Precision Medicine for gMG: Tailoring Treatments Based on Patient Profiles 02/04/2025

Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial 01/04/2025

Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies 31/03/2025

« Primera ‹ Anterior 1 ... 9 10 11 12 13 ... 21 Siguiente › Última »